Loading...
Next Day DeliveryRegistered Pharmacy100% OnlineFully Inspected & Regulated ServicesApproved UK-licensed TreatmentsNext Day DeliveryRegistered Pharmacy100% OnlineFully Inspected & Regulated ServicesApproved UK-licensed TreatmentsPrivate, clinician-led weight loss support designed around your goals, lifestyle and pace.
The body naturally tries to hold onto weight, it is designed to protect you from hunger and energy loss
When you cut calories, hunger hormones like ghrelin rise and metabolism slows, making it harder to keep weight off.
Medical options such as Wegovy® and Mounjaro® work with your body’s biology to help regulate appetite and support lasting progress alongside lifestyle changes and clinical care.
The body naturally tries to hold onto weight, it is designed to protect you from hunger and energy loss
When you cut calories, hunger hormones like ghrelin rise and metabolism slows, making it harder to keep weight off.
Medical options such as Wegovy® and Mounjaro® work with your body’s biology to help regulate appetite and support lasting progress alongside lifestyle changes and clinical care.
Start with a quick BMI check. It takes a moment. You will see where you are today and what a healthy range looks like. And if you want support, we’re here for that too.
Enter your weight & height to get an indication of where your BMI stands.
Your eligibility is assessed by our clinicians based on your BMI, medical history, current medications and previous treatment experience.
| Criteria | Typical Guidance |
|---|---|
BMI 30+ | Usually eligible |
| BMI 27+ with health conditions | Often eligible |
| Existing medications |
.png&w=1116&q=75)
Small daily habits make a big difference.
Answer a few questions at your own pace. A UK clinician will review your answers, and if treatment’s right for you, we will handle the prescription and discreet delivery.
Unmarked packaging, low-key updates, and your details kept safe. No waiting rooms, no awkward chats, just care on your terms.
Our clinicians listen, guide, and help you make confident choices about your health at your pace.
Every assessment is private, judgment-free, and reviewed by a qualified prescriber.
Co-Founder & Chief Strategy Officer
Chief Executive Officer
%252C%2520MBA%2520Henley%2520-%2520LYV%2520Pharmacy.png%2520(1).webp&w=1440&q=75)
Chief People Officer
Chief Technology Officer
Director of Pharmacy Operations
Skincare & Aesthetics Specialist
| Reviewed by clinician |
| Previous GLP-1 use | Assessed individually |
This helps build trust, set clear expectations and reduce drop-off.
Have a concern or experiencing side effects? Send us a message. We will keep things simple, use clear language, and check in after you start.
Answer a few questions at your own pace. A UK clinician will review your answers, and if treatment’s right for you, we will handle the prescription and discreet delivery.
Unmarked packaging, low-key updates, and your details kept safe. No waiting rooms, no awkward chats, just care on your terms.
Have a concern or experiencing side effects? Send us a message. We will keep things simple, use clear language, and check in after you start.
15 Products
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£99.00
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£187.00
This product will be available on July 21, 2026.
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£129.00
This product will be available on July 21, 2026.
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.Coming soonWegovy Pill availability through LYV is expected from 6 July 2026. Register your interest to receive an update when treatment becomes available.Availability is subject to confirmed stock, completion of a clinical assessment and approval by a qualified prescriber.
£109.00
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£257.39
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£292.04
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£232.64
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£163.34
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£272.24
Filter
